# Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital

> **NCT00478790** · PHASE3 · UNKNOWN · sponsor: **Pro Top & Mediking Company Limited** · enrollment: 60 (estimated)

## Conditions studied

- Glaucomas
- Pterygium

## Interventions

- **DEVICE:** ologen™ Collagen matrix implantation in glaucoma filtering surgery

## Key facts

- **NCT ID:** NCT00478790
- **Lead sponsor:** Pro Top & Mediking Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478790, "Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00478790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*